Skip to main content

Table 2 Frequencies of LA abnormalities in the study population

From: Incidence of left atrial abnormalities under treatment with dabigatran, rivaroxaban, and vitamin K antagonists

  VKA, n = 138 (45 %) Dabigatran, n = 68 (22 %) Rivaroxaban, n = 100 (33 %) p value for difference between VKA and Dabigatran p value for difference between VKA and Rivaroxaban pvalue for difference between dabigatran and rivaroxaban
LA/LAA thrombus 5 (4 %) 0 (0 %) 2 (2 %) 0.173 0.515 0.702
Dense SEC 2 (1 %) 1 (1 %) 2 (2 %) 1 1 1
LAAV <20 cm/s 5 (4 %) 1 (1 %) 1 (1 %) 0.666 1 0.405
LA abnormality 12 (9 %) 2 (3 %) 5 (5 %) 0.15 0.702 0.318
  1. LA left atrium, LAA left atrial appendage, LAAV left atrial appendage velocity, SEC spontaneous echo contrast, VKA vitamin K antagonists